Zemplar and fatigue Patient Reports February 10, 2012

Zemplar Side Effects Report #5576828-1
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Dec 22, 2007. Male patient, 70 years of age, weighting 144.0 lb, was diagnosed with secondary hypothyroidism, insomnia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthenia, blood glucose decreased, blood glucose increased, dialysis device complication, fall , fatigue, haematoma, oedema peripheral, pain . Zemplar dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, INSULIN, INSULIN NOVOMIX. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5581500-8
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Dec 22, 2007. Male patient, 70 years of age, weighting 144.0 lb, was diagnosed with secondary hypothyroidism, insomnia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthenia, blood glucose decreased, blood glucose increased, catheter site haemorrhage, dialysis device complication, fall , fatigue, haematoma, oedema peripheral. Zemplar dosage: unknown. During the same period patient was treated with PARACETAMOL, INSULIN, INSULIN NOVOMIX. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5694995-6
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Mar 26, 2008. Male patient, 70 years of age, weighting 144.0 lb, was diagnosed with secondary hypothyroidism, insomnia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthenia, blood glucose decreased, blood glucose increased, dialysis device complication, fall , fatigue, haematoma, oedema peripheral, pain . Zemplar dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, INSULIN, INSULIN NOVOMIX. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5756010-5
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 05, 2008. Male patient, weighting 180.2 lb, was diagnosed with renal disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: constipation , diarrhoea, dysgeusia, fatigue. Zemplar dosage: unknown. During the same period patient was treated with DOXERCALCIFEROL. Patient recovered.


Zemplar Side Effects Report #5932484-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Oct 23, 2008. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer , dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, FOLIC ACID, NEUROGRISEVIT, EVATON, BUFLOMEDIL HYDROCHLORIDE, SEVELAMER. Patient was hospitalized. Patient died on 07/31/2008.

Zemplar Side Effects Report #5977781-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Nov 27, 2008. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer , dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, FOLIC ACID, NEUROGRISEVIT, EVATON, BUFLOMEDIL HYDROCHLORIDE, SEVELAMER. Patient was hospitalized. Patient died on 07/31/2008.

Zemplar Side Effects Report #5979911-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 05, 2008. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer , dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, FOLIC ACID, NEUROGRISEVIT, EVATON, BUFLOMEDIL HYDROCHLORIDE, SEVELAMER. Patient was hospitalized. Patient died on 07/31/2008.

Zemplar Side Effects Report #6110944-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Mar 04, 2009. Male patient, 81 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anorexia, bladder cancer , cardio-respiratory arrest, dyspnoea, fatigue. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, COSMOFER, SUPERAMIN, FILICINE, NEUROBION, EVATON, LOFTYL, RENAGEL. Patient was hospitalized. Patient died on 07/31/2008.

Zemplar Side Effects Report #5886808-4
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 13, 2008. Male patient, 74 years of age, weighting 174.4 lb, was diagnosed with hyperparathyroidism secondary, gastric disorder, blood glucose increased, vitamin supplementation, thrombosis prophylaxis, blood disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arrhythmia , blood glucose increased, cerebrovascular accident, cough, exercise tolerance decreased, fatigue, foot fracture, gangrene, impaired healing. Zemplar dosage: 5MCG/ML, 4ML/WEEK. During the same period patient was treated with DIMETICONE, INSULIN, INSULIN GLARGINE, PARENTROVITE, VITAMIN E, CALCIUM CARBONATE, CLOPIDOGREL, ACETYL SALICYLIC ACID COMPOUND. Patient was hospitalized. Patient died on 08/29/2008.


Zemplar Side Effects Report #5900099-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 23, 2008. Male patient, 74 years of age, weighting 174.4 lb, was diagnosed with hyperparathyroidism secondary, gastric disorder, blood glucose increased, vitamin supplementation, thrombosis prophylaxis, blood disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arrhythmia , blood glucose increased, cerebrovascular accident, cough, exercise tolerance decreased, fatigue, foot fracture, gangrene, impaired healing. Zemplar dosage: 5MCG/ML, 4ML/WEEK. During the same period patient was treated with DIMETICONE, INSULIN, INSULIN GLARGINE, PARENTROVITE, VITAMIN E, CALCIUM CARBONATE, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient died on 08/29/2008.

Zemplar Side Effects Report #5764403-5
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on June 02, 2008. Male patient, 63 years of age, was diagnosed with hyperparathyroidism, angina unstable and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina unstable, dizziness , fatigue, gastrointestinal haemorrhage. Zemplar dosage: 5MCG/ML, 2 ML PER WEEK. During the same period patient was treated with ASPIRIN, CLOPIDOGREL, HEPARIN. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5840321-9
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 01, 2008. Male patient, 63 years of age, weighting 131.2 lb, was diagnosed with hyperparathyroidism, angina unstable and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina unstable, faeces discoloured, fatigue, gastrointestinal haemorrhage, presyncope. Zemplar dosage: 5MCG/ML, 2 ML PER WEEK. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CLOPIDOGREL, ENOXAPARIN, BICARBONATE, OMEPRAZOLE, REPAGLINIDE, CALCIUM CARBONATE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5863799-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 19, 2008. Female patient, 59 years of age, was diagnosed with hyperparathyroidism, dialysis , keratoplasty and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood creatinine increased, c-reactive protein increased, cerebral infarction, fatigue, hyponatraemia, leukocytosis, oxygen saturation decreased. Zemplar dosage: unknown. During the same period patient was treated with DIAZEPAM, FLOXACILLIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5871178-8
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 04, 2008. Female patient, 59 years of age, was diagnosed with hyperparathyroidism, dialysis , keratoplasty and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood creatinine increased, c-reactive protein increased, cerebral infarction, fatigue, hyponatraemia, leukocytosis, oxygen saturation decreased. Zemplar dosage: unknown. During the same period patient was treated with DIAZEPAM, FLOXACILLIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5875716-0
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 04, 2008. Male patient, 48 years of age, weighting 132.7 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acinetobacter infection, enterococcal infection, fatigue, feeling hot, impaired healing, ischaemia, malaise, oedema peripheral, osteitis. Zemplar dosage: 5 MCG/ML, 20 MCG/WEEK. During the same period patient was treated with PARENTROVITE, DEXTROPROPOXYPHENE NAPSILATE, SIMVASTATIN, CLOPIDOGREL, BICARBONATE, ALLOPURINOL, AMITRIPTYLINE HYDROCHLORIDE, MINTARA. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #6098276-0
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2009. Male patient, weighting 173.2 lb, was diagnosed with hyperparathyroidism, abdominal discomfort, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fatigue, heart rate decreased. Zemplar dosage: unknown. During the same period patient was treated with DEMADEX, VITAMINS WITH IRON, ASPIRIN, ANTACID, ENALAPRIL, BAUSCH. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5711828-X
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 11, 2008. Male patient, 57 years of age, was diagnosed with glomerulonephritis chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina pectoris, atrial fibrillation , colitis, dialysis , fatigue, gastroenteritis , headache , pallor. Zemplar dosage: unknown. During the same period patient was treated with OMEPRAZOLE, BEVITOTAL COMP, ACETYLSALICYLIC ACID SRT, BETOLVIDON, FOLACIN, METOPROLOL SUCCINATE, SIMVASTATIN, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5620697-8
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Jan 31, 2008. Female patient, 61 years of age, was diagnosed with blood calcium, blood phosphorus, prophylaxis, gastrooesophageal reflux disease, constipation prophylaxis, cardiovascular event prophylaxis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anxiety , blood glucose increased, blood pressure increased, depressed mood, fatigue, micturition urgency, pain , thrombosis, urinary bladder haemorrhage. Zemplar dosage: 5MCG/ML. During the same period patient was treated with ZEMPLAR SOLUTION FECTION, BICARBONATE, BICARBONATE, OMEPRAZOLE, LACTULOSE, PARENTROVITE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5684206-X
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Mar 25, 2008. Female patient, 61 years of age, was diagnosed with blood calcium, blood phosphorus, prophylaxis, gastrooesophageal reflux disease, constipation prophylaxis, cardiovascular event prophylaxis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anxiety , blood glucose increased, blood pressure increased, depressed mood, fatigue, micturition urgency, pain , thrombosis, urinary bladder haemorrhage. Zemplar dosage: 5MCG/ML. During the same period patient was treated with BICARBONATE, BICARBONATE, OMEPRAZOLE, LACTULOSE, PARENTROVITE. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5859163-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 19, 2008. Male patient, 48 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: acinetobacter infection, enterococcal infection, fatigue, feeling hot, impaired healing, ischaemia, malaise, oedema peripheral, osteitis. Zemplar dosage: 5 MCG/ML, 20 MCG/WEEK. During the same period patient was treated with PARENTROVITE, DEXTROPROPOXYPHENE NAPSILATE, SIMVASTATIN, CLOPIDOGREL, BICARBONATE, ALLOPURINOL, AMITRIPTYLINE HYDROCHLORIDE, MINTARA. Patient was hospitalized. Patient recovered.